Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Implementing HIV-1 genotypic resistance testing in antiretroviral therapy programs in Africa: needs, opportunities, and challenges.

AIDS reviews - 1 Jan 2000

Lessells Richard J, Avalos Ava, de Oliveira Tulio

Abstract excerpt

Tremendous progress has been made with the scale-up of antiretroviral therapy in Africa, with an estimated seven million people now receiving antiretroviral therapy in the region. The long-term success of antiretroviral therapy programs depends on appropriate strategies to deal with potential threats, one of which is the emergence and spread of antiretroviral drug resistance. Whilst public health surveillance...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Africa
Share to Anti-HIV Agents
Share to Cost-Benefit Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Genotype

Share to HIV Infections

Share to World Health Organization

Source

Open in PubMed Open full text

Identifiers

PMID: 24322382
PMCID: PMC3951902

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Implementing HIV-1 genotypic resistance testing in antiretroviral therapy programs in Africa: needs, opportunities, and challenges.PMID 24322382Read ↗

Update on HIV-1 acquired and transmitted drug resistance in Africa.Semantic proximity Read ↗

Implementing antiretroviral resistance testing in a primary health care HIV treatment programme in rural KwaZulu-Natal, South Africa: early experiences, achievements and challenges.Semantic proximity Read ↗

Increasing HIV-1 Drug Resistance Between 2010 and 2012 in Adults Participating in Population-Based HIV Surveillance in Rural KwaZulu-Natal, South Africa.Semantic proximity Read ↗

Using HIV resistance tests in clinical practice.Semantic proximity Read ↗

Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens.Semantic proximity Read ↗

Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa.Semantic proximity Read ↗

Prevalence of HIV-1 drug resistance among women screening for HIV prevention trials in KwaZulu-Natal, South Africa (MTN-009).Semantic proximity Read ↗

The challenge of HIV-1 antiretroviral resistance in Africa in the era of HAART.Semantic proximity Read ↗

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited SettingsSemantic proximity Read ↗

Evaluation of transmitted HIV drug resistance among recently-infected antenatal clinic attendees in four Central African countries.Semantic proximity Read ↗

Genotypic resistance profiles of HIV-2-treated patients in West Africa.Semantic proximity Read ↗

Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.